why choose us

First received: January 15, 2025

Clinical Trial: A Study to Explore the Efficacy of JNJ-89495120 in the Treatment of Major Depressive Disorder

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Depressive Disorder, Major

Study Type: INTERVENTIONAL


Official Title: A Randomized, Double-blind, Multicenter, Placebo-controlled, Proof-of-Concept Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-89495120 as Monotherapy in Adult Participants With Major D

Brief Summary: The purpose of this study is to evaluate how well JNJ-89495120 works (anti-depressant effects) and how well it is tolerated as compared to placebo on reducing the symptoms of depression in participants with major depressive disorder (MDD).

Read more